RevOpsis Therapeutics has filed a notice of an exempt offering of securities to raise $7,895,004.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, RevOpsis Therapeutics is raising $7,895,004.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Ramanath Bhandari played a key role…